Search Results for: Takeda
Trials & Approvals Breast Cancer
Eli Lilly’s Early Breast Cancer Drug Gets FDA Nod but Faces Tricky Rollout
2021-10-14
Licensing Gene Therapy
Takeda Inks $3.6 Billion Deal with Poseida to Advance Non-Viral Gene Therapies and Overcome Safety Issues
2021-10-13
Licensing Gene Therapy
Takeda Embarks On a Billion-Dollar Gene Therapy Deal with Selecta Biosciences
2021-10-08
Takeda Hits the Brakes on Narcolepsy Drug Trials
2021-10-07
M&A Amyloidosis
AstraZeneca Acquires Caelum in $500m Deal to Strengthen Rare Diseases Division
2021-09-30
Special Cell and Gene Therapy
What Does It Take for a Cell & Gene Therapy Program to Go Commercial?
2021-09-30
Asia-Pacific Stem Cell Therapy
Takeda’s Allogeneic Stem Cell Therapy Becomes First of Its Kind to Be Approved in Japan
2021-09-28
COVID-19 Vaccine
Takeda to Supply 150 Million Doses of Novavax COVID-19 Vaccine to Japan
2021-09-08
Ranking & Reports RNA Editing
The 6 Companies Leading the Resurgence in RNA Editing R&D
2021-08-24
Liver Disease
Takeda To Develop Rare Liver Disease Treatments with Genevant in $303M Pact
2021-08-24
Trials & Approvals
J&J’s FDA-Approved Bispecific Antibody Registers Promising Phase 1 Results for a Different Indication
2021-08-20
Deals Partner
A Boom in High-Value M&A and Licensing Deals in the Exosome Field
2021-08-02
Deals Neuroscience
Takeda Signs New Deal with PeptiDream Spending Billions to Develop Neuromuscular Disease Drugs
2021-07-30
Trials & Approvals NSCLC
FoundationOne CDx Okayed as Companion Diagnostic for Takeda’s Lung Cancer Drug
2021-07-04
M&A Multiple Myeloma
AbbVie to Acquire TeneoOne and Its Lead Multiple Myeloma Drug
2021-06-27
1 … 3 4 5 6 7 … 10
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top